Imagine Apple halting iPhone production because studies linked smartphones to teen suicide rates. Imagine Pfizer proactively pulling Lipitor because of internal studies showing increased cardiac risk, and not because of looming settlements or FDA injunction, just for the health of patients. Or imagine if in 1952, Philip Morris halted expansion and stopped advertising when Wynder & Graham first showed heavy smokers had significantly elevated rates of lung cancer.

It wouldn't happen. Corporations will on occasion pull products for safety reasons: Samsung did so with the Galaxy Note over spontaneous combustion concerns and Merck pulled Vioxx – but they do so when forced by backlash, regulation, or lawsuits. Even then, they fight tooth and nail. Especially for their mainstay, core, and most profitable products.

And yet, Anthropic has done exactly that.

On Monday, the company announced that it will be pausing development of further Claude AI models citing safety concerns. The company clarified that existing services, including the chatbot, Claude Code, and programmer APIs will not be impacted. However they are pausing the compute and energy-intensive training runs that are how new and more powerful AI versions are created. The company has not committed to a timeline for resumption.

[...]

---

First published:

Source:

---

Narrated by TYPE III AUDIO.

---

Images from the article:

Apple Podcasts and Spotify do not show images in the episode description. Try Pocket Casts, or another podcast app.